BioPlus Acquisition Corp (BIOS)
$10.80
$0.00 (0.00%)As on 13-Oct-2023 09:30EDT
Market cap
$209 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
51.4
P/B Ratio
0
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$3 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
19,367,500
10 Years Aggregate
CFO
$-215.88 Mln
EBITDA
$-715.38 Mln
Net Profit
$-712.34 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BioPlus Acquisition Corp (BIOS)
| 5.6 | -0.4 | 1.5 | 7.4 | -- | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BioPlus Acquisition Corp (BIOS)
|
10.8 | 209.1 | 0.0 | 11.9 | -- | 6.5 | 51.4 | 0.0 |
| 10.1 | 295.6 | 0.0 | -7.4 | -- | -- | -- | 4.2 |
Shareholding Pattern
View DetailsAbout BioPlus Acquisition Corp (BIOS)
BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life... sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York. Read more
-
Chairman & Chief Bus. Officer
Mr. Jonathan M. N. Rigby MBA
-
Chairman & Chief Bus. Officer
Mr. Jonathan M. N. Rigby MBA
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for BioPlus Acquisition Corp (BIOS)
What is the current share price of BioPlus Acquisition Corp (BIOS) Today?
The share price of BioPlus Acquisition Corp (BIOS) is $10.80 (NASDAQ) as of 13-Oct-2023 09:30 EDT. BioPlus Acquisition Corp (BIOS) has given a return of 7.41% in the last 1 years.
What is the current PB & PE ratio of BioPlus Acquisition Corp (BIOS)?
The P/E ratio of BioPlus Acquisition Corp (BIOS) is 51.40 times as on 13-Oct-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-- |
-- |
2021 |
-- |
-- |
2018 |
-- |
-- |
2017 |
-- |
-- |
2016 |
-- |
-- |
What is the 52 Week High and Low of BioPlus Acquisition Corp (BIOS)?
The 52-week high and low of BioPlus Acquisition Corp (BIOS) are Rs -- and Rs -- as of 30-Aug-2026.
What is the market cap of BioPlus Acquisition Corp (BIOS)?
BioPlus Acquisition Corp (BIOS) has a market capitalisation of $ 209 Mln as on 13-Oct-2023. As per SEBI classification, it is a company.
Should I invest in BioPlus Acquisition Corp (BIOS)?
Before investing in BioPlus Acquisition Corp (BIOS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.